Cellular uptake and biological effects of antisense oligodeoxynucleotide analogs targeted to herpes simplex virus

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1670-1675

  Shoji, Yoko ^a   Shimada, Jingoro ^a   Mizushima, Yutaka ^a   Iwasawa, Atsuo ^b   Nakamura, Yoshiko ^b   Inouye, Kazuhiro ^c   Azuma, Teruyoshi ^c   Sakurai, Masayuki ^c   Nishimura, Tateo ^c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Roman Industry Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTIVIRUS AGENT; FLUORESCEIN ISOTHIOCYANATE; MESSENGER RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONFOCAL LASER MICROSCOPY; DRUG BIOAVAILABILITY; DRUG MECHANISM; HERPES SIMPLEX VIRUS; IMMEDIATE EARLY GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0030011097     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1670     Document Type: Article

References (25)

1. Agrawal, S. 1992. Antisense oligonucleotides as antiviral agents. Trends Biotechnol. 10:152-158.
2. Akhtar, S., Y. Shoji, and R. L. Juliano. 1992. Pharmaceutical aspects of the biological stability and membrane transport characteristics of antisense oligonucleotides, p. 133-145. In R. P. Erickson and J. G. Izant (ed.), Gene regulation: biology of antisense RNA and DNA. Pappenheim Ltd., New York.
3. Asseline, U., T. Geiser, and G. Zon. 1989. Synthesis of antisense phosphorothioate analogues for pharmacokinetics and pre-clinical studies. Nucleosides Nucleotides 8:967-970.
4. Gao, W.-Y., R. N. Hanes, M. A. Vazquez-Padua, C. A. Stein, J. S. Cohen, and Y.-C. Cheng. 1990. Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob. Agents Chemother. 34:808-812.
5. Gao, W.-Y., J. W. Jaroszewski, J. S. Cohen, and Y.-C. Cheng. 1990. Mechanism of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. J. Biol. Chem. 265:20172-20178.
6. Gewirtz, A. M. 1992. Therapeutic application of antisense DNA in the treatment of human leukemia. Ann. N. Y. Acad. Sci. 660:178-187.
7. Goodchild, J. 1990. Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconjugate Chem. 1:165-187.
8. Krieg, A. M., J. Tonkinson, S. Matson, Q. Zhao, M. Saxon, L.-M. Zhang, U. Bhanja, L. Yakubov, and C. A. Stein. 1993. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc. Natl. Acad. Sci. USA 90:1048-1052.
9. Kulka, M., C. Smith, L. Aurelian, R. Fishelevich, K. Meade, P. Miller, and P. O. P. Ts'o. 1989. Site specificity of the inhibitory effects of oligo(nucleotide methylphosphonates) complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA. Proc. Natl. Acad. Sci. USA 86:6868-6872.
10. Leonetti, J. P., G. Degols, and B. Lebleu. 1990. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjugate Chem. 1:149-153.
11. Loke, S. L., C. Stein, X. H. Zhang, K. Mori, M. Nakanishi, C. Subasinghe, J. S. Cohen, and L. M. Neckers. 1989. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86:3474-3478.
12. Majundar, C., C. A. Stein, J. S. Cohen, S. Broder, and S. H. Wilson. 1989. HIV reverse transcriptase stepwise mechanism: phosphorothioate oligodeoxynucleotide as primer. Biochemistry 28:1340-1346.
13. Matsukura, M., K. Shinozuka, G. Zon, H. Mitsuya, M. Reitz, J. S. Cohen, and S. Broder. 1987. Phosphorothioate analogues of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 84:7706-7710.
14. Miller, P. S., K. B. McParland, K. Jayaraman, and P. O. P. Ts'o. 1981. Biochemical and biological effects of nonionic nucleic acid methylphosphonates. Biochemistry 20:1874-1880.
15. Miller, P. S., and P. O. P. Ts'o. 1987. A new approach to chemotherapy based on molecular biology and nucleic acid chemistry:matagen (masking tape for gene expression). Anti-cancer Drug Des. 2:117-128.
16. Miller, P. S., J. Yano, E. Yano, C. Carroll, K. Jayaraman, and P. O. P. Ts'o. 1979. Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphonates. Biochemistry 18:5134-5143.
17. Ming-Yi, C., H. Chan, M. A. Zounes, S. M. Freier, W. F. Lima, and C. F. Bennell. 1991. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 25:18162-18171.
18. Sands, H., J. J. George-Feret, A. J. Cocuzza, F. W. Hobbs, D. Chidester, and G. L. Trainor. 1994. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphorodiester and a phosphorothioate. Mol. Pharmacol. 45:932-943.
19. Shoji, Y., S. Akhtar, A. Periasamy, B. Herman, and R. L. Juliano. 1991. Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. Nucleic Acids Res. 19:5543-5550.
20. Stein, C. A., and Y.-C. Cheng. 1993. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 251:1004-1012.
21. Stein, C. A., K. Mori, S. L. Loke, C. Subasinghe, K. Shinozuka, J. S. Cohen, and L. M. Neckers. 1988. Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake. Gene 72:333-341.
22. Tidd, D. M. 1990. A potential role for untisense oligonucleotide analogues in this development of oncogene targeted cancer chemotherapy. Anticancer Res. 10:1169-1182.
23. Uhlmann, E., and A. Peyman. 1990. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 90:543-584.
24. Whitton, J. L., and B. J. Clements. 1984. The junctions between the repetitive and the short unique sequences of the herpes simplex virus genome are determined by the polypeptide-coding regions of two spliced immediate-early mRNAs. J. Gen. Virol. 65:451-466.
25. Yakubov, L. A., E. A. Deeva, V. F. Zarytova, E. M. Ivanova, A. S. Ryte, L. V. Yurchenko, and V. V. Vlassov. 1989. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA 86:6454-6458.